Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Pediatr Blood Cancer ; 71(7): e31004, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-38637875

RESUMEN

Pleuroparenchymal fibroelastosis (PPFE) is a rare interstitial pneumonia with distinct clinicopathologic features. It has been associated with exposure to hematopoietic stem cell transplantation (HSCT) and classical alkylating agents. Here, we highlight PPFE as a late complication of childhood cancer therapy by describing the cases of four survivors of childhood cancer with a diagnosis of treatment-related PPFE. All patients received high-dose alkylating agents. PPFE should be considered in the differential diagnosis of restrictive lung disease in patients with history of exposure to alkylating agents or HSCT. Development of PPFE-specific, noninvasive diagnostic tools and disease-modifying therapies will clinically benefit these patients.


Asunto(s)
Enfermedades Pulmonares Intersticiales , Humanos , Masculino , Femenino , Niño , Adolescente , Enfermedades Pulmonares Intersticiales/patología , Enfermedades Pulmonares Intersticiales/etiología , Enfermedades Pulmonares Intersticiales/inducido químicamente , Enfermedades Pulmonares Intersticiales/terapia , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Neoplasias/tratamiento farmacológico , Neoplasias/complicaciones , Neoplasias/patología , Fibrosis Pulmonar/etiología , Fibrosis Pulmonar/patología , Preescolar , Antineoplásicos Alquilantes/efectos adversos
2.
JCO Oncol Pract ; 18(9): e1505-e1512, 2022 09.
Artículo en Inglés | MEDLINE | ID: mdl-35749678

RESUMEN

PURPOSE: As the role of clinical ethics consultation in health care advances, there are calls to standardize the process of consultation. The Ethics Committee at Memorial Sloan Kettering Cancer Center (MSK) hypothesized that the process of requesting an ethics consultation could be improved by instituting an electronic health record (EHR) order for consultation requests. This report summarizes the impact of adopting an EHR order for ethics consultation requests at MSK. METHODS: This retrospective review of all clinical ethics consultations requested at a tertiary cancer center from May 2017 to February 2020 spans 17 months before and after implementation of an electronic order for consultation requests. Summary statistics are presented using Pearson chi-square analyses with a significance level of 0.05. RESULTS: There was a significant increase in the total number of consultation requests placed after implementation of the EHR order (n = 165, 0.08% of total patients) compared with before (n = 108, 0.05% of total patients; P = .007). The number of consults requested by providers from inpatient (P = .02) and outpatient (P = .04) settings significantly increased. The proportion of consults placed by medical versus nonmedical providers remained unchanged (P = .32). CONCLUSION: In this large single-institution retrospective study, implementation of an EHR order for ethics consultation requests was associated with a significant increase in the number of consultation requests. Implementation of an electronic order may decrease barriers to ethics consultation in diverse practice settings. Further longitudinal, multicenter studies are needed to assess strategies to improve access to clinical ethics consultation for oncology patients.


Asunto(s)
Consultoría Ética , Atención a la Salud , Registros Electrónicos de Salud , Comités de Ética , Humanos , Estudios Retrospectivos
3.
Ophthalmic Genet ; 43(6): 806-808, 2022 12.
Artículo en Inglés | MEDLINE | ID: mdl-36695494

RESUMEN

Since 2006, ophthalmic artery chemosurgery (OAC) has been used for ocular-sparing treatment of retinoblastoma. Systemic exposure to melphalan is known to cause ovarian dysfunction, but the effect of melphalan-based OAC has not yet been determined. Here, we assess biochemical and symptomatic measures of ovarian function in a cohort of pubertal female survivors of retinoblastoma treated with melphalan-based OAC. These 13 patients all had normal gonadotropins at a median age of 11.1 years, 9.6 years from the completion of therapy. None had symptoms of ovarian dysfunction. This study provides initial evidence that ovarian function remains intact after melphalan-based OAC.


Asunto(s)
Neoplasias de la Retina , Retinoblastoma , Humanos , Femenino , Lactante , Niño , Retinoblastoma/tratamiento farmacológico , Retinoblastoma/cirugía , Melfalán/efectos adversos , Neoplasias de la Retina/tratamiento farmacológico , Carboplatino/uso terapéutico , Electrorretinografía , Topotecan , Resultado del Tratamiento , Infusiones Intraarteriales , Estudios Retrospectivos , Sobrevivientes , Arteria Oftálmica/cirugía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA